“Alcoholic Hepatitis Market” report has been added to DelveInsight
Alcoholic Hepatitis Overview
Alcoholic hepatitis (AH) is an inflammation of the liver caused by years of heavy drinking. The disease can occur in people who drink heavily for less than a year, it is most likely to affect the heavy drinkers and also in some cases, it can affect the people who drink moderately. The most common sign of alcoholic hepatitis is jaundice, yellowing of skin, fatigue, weakness, loss of appetite, abdominal tenderness, nausea, and vomiting.
DelveInsight’s ‘Alcoholic Hepatitis Market Insights, Epidemiology, and Market Forecast – 2030’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of Alcoholic Hepatitis in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Request free sample copy- https://www.delveinsight.com/sample-request/alcoholic-hepatitis-market
Alcoholic Hepatitis Market: Regions covered
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
Alcoholic Hepatitis Market: Key Players
- Afimmune
- Durect
- And many others
Alcoholic Hepatitis Market: Drugs
- DS102
- DUR-928
- And many others
Alcoholic Hepatitis Market: Symptoms
Additional signs and symptoms that occur with severe alcoholic hepatitis include confusion and behavior changes due to a buildup of toxins normally broken down and eliminated by the liver, fluid accumulation in the abdomen, kidney, and liver failure.
Alcoholic Hepatitis Market: Risk Factors
The major risk factor for alcoholic hepatitis is the quantity of alcohol a person consumes. However, alcoholic hepatitis can occur among those who drink less and have other risk factors, such as obesity, gender, genetic factors, race, and ethnicity. It is known that it is an inflammatory disease and also proinflammatory mediators, such as tumor necrosis factor (TNF) plays a critical role in liver injury.
Alcoholic Hepatitis Market: Pathogenesis
The pathogenesis of alcoholic hepatitis is multifactorial; although the current evidence recommends that the damage is the result of the complex interplay between ethanol metabolism, inflammation, and innate immunity. Such metabolic pathways generate reactive oxygen species that are potent inducers of lipid peroxidation, which in turn, causes hepatocyte death by apoptosis.
Alcoholic Hepatitis Market: Outlook
Accurate analytical stratification is crucial for individualized therapeutic decisions in patients with alcoholic hepatitis. Patients with alcoholic hepatitis often suffer from serious malnutrition resulting from loose eating habits, alcohol-related diarrhea, reduced small bowel absorption capacity, anorexia, and a disproportionate catabolic state, which is directly related to increased mortality.
Alcoholic Hepatitis Market: Emerging Drugs Analysis
The dynamics of the Alcoholic Hepatitis market is expected to change in the coming years owing to the improvement in the diagnosis methodologies, increasing awareness of the disease, and incremental healthcare spending across the world. Key players in the therapeutic market of Alcoholic Hepatitis are Durect, Novartis, Afimmune, etc. The launch of emerging therapies, such as DUR-928 (Durect), DS102 (Afimmune), and Canakinumab (Novartis Pharmaceuticals) will significantly impact the AH market during the forecast period (2020–2030).
Following is the Table of content
1 Key Insights
2 Executive Summary of Alcoholic Hepatitis
3 SWOT Analysis for Alcoholic Hepatitis
4 Alcoholic Hepatitis Market Overview at a Glance
5 Alcoholic Hepatitis: Disease Overview
6 Epidemiology and Patient Population
6.1 Key Findings
7 7MM Epidemiology
8 Treatment of Alcoholic Hepatitis
8.1 Treatment Guidelines
9 Unmet Needs
10 Organizations contributing toward AH
11 Case studies
12 KOL Views
13 Emerging Therapies
14 Alcoholic Hepatitis (AH): Seven Major Market Analysis
15 Seven Major Market Outlook
16 Market Drivers
17 Market Barriers
18 Reimbursement
19 Appendix
20 DelveInsight Capabilities
21 Disclaimer
22 About DelveInsight
Why should you buy this report?
- The report will help in developing business strategies by understanding trends shaping and driving the Alcoholic Hepatitis market
- To understand the future market competition in the Alcoholic Hepatitis market and Insightful review of the key market drivers and barriers
- Organize sales and marketing efforts by identifying the best opportunities for Alcoholic Hepatitis in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom), and Japan
- Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
- Organize sales and marketing efforts by identifying the best opportunities for the Alcoholic Hepatitis market
- To understand the future market competition in the Alcoholic Hepatitis market
Related Reports
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/